Filter News
Area of Research
News Topics
- (-) Biomedical (6)
- (-) Isotopes (1)
- (-) Mercury (1)
- (-) Neutron Science (19)
- 3-D Printing/Advanced Manufacturing (13)
- Advanced Reactors (1)
- Artificial Intelligence (7)
- Big Data (1)
- Bioenergy (8)
- Biology (3)
- Biotechnology (3)
- Buildings (2)
- Chemical Sciences (5)
- Climate Change (6)
- Composites (2)
- Computer Science (14)
- Coronavirus (7)
- Cybersecurity (1)
- Decarbonization (6)
- Energy Storage (9)
- Environment (9)
- Exascale Computing (4)
- Frontier (4)
- Grid (3)
- High-Performance Computing (9)
- Machine Learning (4)
- Materials (10)
- Materials Science (10)
- Microscopy (4)
- Molten Salt (1)
- Nanotechnology (9)
- National Security (3)
- Net Zero (1)
- Nuclear Energy (3)
- Partnerships (4)
- Physics (4)
- Polymers (2)
- Quantum Science (5)
- Renewable Energy (1)
- Security (1)
- Simulation (2)
- Summit (5)
- Sustainable Energy (10)
- Transformational Challenge Reactor (2)
- Transportation (9)
Media Contacts
Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
Using neutrons to see the additive manufacturing process at the atomic level, scientists have shown that they can measure strain in a material as it evolves and track how atoms move in response to stress.
The Spallation Neutron Source — already the world’s most powerful accelerator-based neutron source — will be on a planned hiatus through June 2024 as crews work to upgrade the facility. Much of the work — part of the facility’s Proton Power Upgrade project — will involve building a connector between the accelerator and the planned Second Target Station.
After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.
The Spallation Neutron Source at the Department of Energy's Oak Ridge National Laboratory set a world record when its particle accelerator beam operating power reached 1.7 megawatts, substantially improving on the facility’s original design capability.
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.